Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - It's got to be S&L - who else can sell and still make a profit at .45?

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

patientman

Rank: Treasurer [?]

Points: 4701 [?]

Votes: 89 Score: 2.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

It's got to be S&L - who else can sell and still make a profit at .45?

posted on Sep 07, 2007 12:10PM

It would be nice if JT would state the following in his next report:

"By the way - our investors should note that our largest shareholder, S&L, is and has been decreasing their position in Patriot Scientific which has unfortunately contributed to our withering share price. They have been doing most of their selling when we announce a new license or announce good news in order to do minimal damage to our stock price. They plan to stop selling when their holdings are approximately 5 million shares."